These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 28333757

  • 21. Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study.
    Arishi H, AlQahtani S, Tamim H, Sadat M, Alenezi FZ, Bin Humaid F, AlWehaibi W, Arabi YM.
    J Crit Care; 2022 Dec; 72():154121. PubMed ID: 35908329
    [Abstract] [Full Text] [Related]

  • 22. Low-dose vasopressin in the treatment of septic shock in sheep.
    Sun Q, Dimopoulos G, Nguyen DN, Tu Z, Nagy N, Hoang AD, Rogiers P, De Backer D, Vincent JL.
    Am J Respir Crit Care Med; 2003 Aug 15; 168(4):481-6. PubMed ID: 12791578
    [Abstract] [Full Text] [Related]

  • 23. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial.
    Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, Brett SJ.
    Crit Care Med; 2014 Jun 15; 42(6):1325-33. PubMed ID: 24557425
    [Abstract] [Full Text] [Related]

  • 24. A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.
    He X, Su F, Taccone FS, Laporte R, Kjølbye AL, Zhang J, Xie K, Moussa MD, Reinheimer TM, Vincent JL.
    Crit Care Med; 2016 Jan 15; 44(1):23-31. PubMed ID: 26496451
    [Abstract] [Full Text] [Related]

  • 25. The effects of vasopressin on acute kidney injury in septic shock.
    Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, Storms MM, Holmes CL, Hébert PC, Cooper DJ, Mehta S, Granton JT, Cook DJ, Presneill JJ.
    Intensive Care Med; 2010 Jan 15; 36(1):83-91. PubMed ID: 19841897
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
    Erwin BL, Denaburg MA, Barker AB, McArdle PJ, Windham ST, Morgan CJ.
    Crit Care Med; 2017 Dec 15; 45(12):e1226-e1232. PubMed ID: 28991825
    [Abstract] [Full Text] [Related]

  • 27. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N, Altshuler D, Merchan C, Zakhary B, Aberle C, Papadopoulos J.
    Ann Pharmacother; 2018 Aug 15; 52(8):733-739. PubMed ID: 29560736
    [Abstract] [Full Text] [Related]

  • 28. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
    Sacha GL, Lam SW, Duggal A, Torbic H, Reddy AJ, Bauer SR.
    Pharmacotherapy; 2018 Mar 15; 38(3):319-326. PubMed ID: 29328496
    [Abstract] [Full Text] [Related]

  • 29. Vasopressin and its immune effects in septic shock.
    Russell JA, Walley KR.
    J Innate Immun; 2010 Mar 15; 2(5):446-60. PubMed ID: 20606409
    [Abstract] [Full Text] [Related]

  • 30. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.
    Gordon AC, Wang N, Walley KR, Ashby D, Russell JA.
    Chest; 2012 Sep 15; 142(3):593-605. PubMed ID: 22518026
    [Abstract] [Full Text] [Related]

  • 31. External Corroboration That Corticosteroids May Be Harmful to Septic Shock Endotype A Patients.
    Wong HR, Hart KW, Lindsell CJ, Sweeney TE.
    Crit Care Med; 2021 Jan 01; 49(1):e98-e101. PubMed ID: 33156120
    [Abstract] [Full Text] [Related]

  • 32. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
    Hammond DA, McCain K, Painter JT, Clem OA, Cullen J, Brotherton AL, Chopra D, Meena N.
    J Intensive Care Med; 2019 Oct 01; 34(10):805-810. PubMed ID: 28618919
    [Abstract] [Full Text] [Related]

  • 33. Elevated Plasma Angiopoietin-2 Levels Are Associated With Fluid Overload, Organ Dysfunction, and Mortality in Human Septic Shock.
    Fisher J, Douglas JJ, Linder A, Boyd JH, Walley KR, Russell JA.
    Crit Care Med; 2016 Nov 01; 44(11):2018-2027. PubMed ID: 27441903
    [Abstract] [Full Text] [Related]

  • 34. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
    Menich BE, Miano TA, Patel GP, Hammond DA.
    Ann Pharmacother; 2019 Sep 01; 53(9):877-885. PubMed ID: 30957512
    [Abstract] [Full Text] [Related]

  • 35. Use of vasopressin in the treatment of refractory septic shock.
    Kny KT, Ferreira MAP, Pizzol TDSD.
    Rev Bras Ter Intensiva; 2018 Sep 01; 30(4):423-428. PubMed ID: 30570030
    [Abstract] [Full Text] [Related]

  • 36. Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients.
    Russell JA, Vincent JL, Kjølbye AL, Olsson H, Blemings A, Spapen H, Carl P, Laterre PF, Grundemar L.
    Crit Care; 2017 Aug 15; 21(1):213. PubMed ID: 28807037
    [Abstract] [Full Text] [Related]

  • 37. Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.
    Pettilä V, Merz T, Wilkman E, Perner A, Karlsson S, Lange T, Hästbacka J, Hjortrup PB, Kuitunen A, Jakob SM, Takala J.
    Trials; 2016 Aug 02; 17():384. PubMed ID: 27484695
    [Abstract] [Full Text] [Related]

  • 38. Effect of norepinephrine on the outcome of septic shock.
    Martin C, Viviand X, Leone M, Thirion X.
    Crit Care Med; 2000 Aug 02; 28(8):2758-65. PubMed ID: 10966247
    [Abstract] [Full Text] [Related]

  • 39. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC, Portuguese Community-Acquired Sepsis Study Group.
    Crit Care Med; 2009 Feb 02; 37(2):410-6. PubMed ID: 19114885
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY, Stollings JL, Wheeler AP, Semler MW, Rice TW.
    Ann Pharmacother; 2017 Jan 02; 51(1):13-20. PubMed ID: 27630192
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.